1. Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year period

   • Caroline Svenjeby
   • Louise Carstam
   • Alba Corell

   Research Open access 25 November 2022 Pages: 535 - 543

   

2. Endoscopic endonasal approach for resection of a recurrent spheno-orbital meningioma resulting in complete resolution of visual symptoms: A case report and review of literature

   • Won Kim
   • Farinaz Ghodrati
   • Isaac Yang

   Review Open access 29 November 2022 Pages: 545 - 553

   

3. High-grade glioma imaging volumes and survival: a single-institution analysis of 101 patients after resection using intraoperative MRI

   • Nicholas T. Gamboa
   • Brendan Crabb
   • Randy L. Jensen

   Research 17 November 2022 Pages: 555 - 565

   

4. Resection extent and BRAF V600E mutation status determine postoperative tumor growth velocity in pediatric low-grade glioma: results from a single-center cohort analysis

   • David Gorodezki
   • Julian Zipfel
   • Martin U. Schuhmann

   Case Study Open access 01 November 2022 Pages: 567 - 576

   

5. The role of [¹⁸F]fluorodopa positron emission tomography in grading of gliomas

   • Joy R. Roach
   • Puneet Plaha
   • Geoff S. Higgins

   Review Open access 24 November 2022 Pages: 577 - 589

   

6. Radiosurgery fractionation and post-treatment hemorrhage development for intact melanoma brain metastases

   • Grant McKenzie
   • Jeremy Gaskins
   • Shiao Woo

   Case Study 01 November 2022 Pages: 591 - 599

   

7. Expression of ABCB1, ABCC1 and 3 and ABCG2 in glioblastoma and their relevance in relation to clinical survival surrogates

   • Laurent-Olivier Roy
   • Myriam Lemelin
   • David Fortin

   Research 07 November 2022 Pages: 601 - 609

   

8. Correlation of reduced temporal muscle thickness and systemic muscle loss in newly diagnosed glioblastoma patients

   • Cecil ten Cate
   • Sandra M. H. Huijs
   • Martinus P. G. Broen

   Research Open access 17 November 2022 Pages: 611 - 618

   

9. Neurocognition in adults with intracranial tumors: does location really matter?

   • Charlotte Sleurs
   • Catharina M. L. Zegers
   • Daniëlle B. P. Eekers

   Research Open access 08 November 2022 Pages: 619 - 629

   

10. Efficacy and safety of immune checkpoint inhibitors plus anlotinib in small cell lung cancer with brain metastases: a retrospective, multicentre study

    • Shujie Zhou
    • Fei Ren
    • Zhaoqin Huang

    Research 08 November 2022 Pages: 631 - 642

    

11. Long term survivors of stereotactic radiosurgery for brain metastases: do distant brain failures reach a plateau and what factors are associated with a brain metastasis velocity of zero?

    • Claire M. Lanier
    • Jane Pearce
    • Michael D. Chan

    Research 06 November 2022 Pages: 643 - 648

    

12. Neurocognitive functioning after Gamma Knife and LINAC stereotactic radiosurgery in patients with brain metastases

    • Elaine A. C. Albers
    • Michiel B. de Ruiter
    • Sanne B. Schagen

    Research 01 December 2022 Pages: 649 - 658

    

13. High dose craniospinal irradiation as independent risk factor of permanent alopecia in childhood medulloblastoma survivors: cohort study and literature review

    • C. Satragno
    • A. Verrico
    • L. Belgioia

    Research Open access 12 November 2022 Pages: 659 - 668

    

14. Utility of 5-ALA for fluorescence-guided resection of brain metastases: a systematic review

    • Harshal A. Shah
    • Sandra Leskinen
    • Randy S. D’Amico

    Review 12 November 2022 Pages: 669 - 675

    

15. Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres

    • Seo Jin Kim
    • Soo Jeong Park
    • Seok-Gu Kang

    Research 17 November 2022 Pages: 677 - 689

    

16. Utilization of neoadjuvant stereotactic radiosurgery for the treatment of brain metastases requiring surgical resection: a topic review

    • Sujay Rajkumar
    • Yun Liang
    • Matthew J. Shepard

    Review 14 November 2022 Pages: 691 - 705

    

17. Performing real time neuropsychological testing during awake craniotomy: are dexmedetomidine or propofol the same? A preliminary report

    • Barbara Tomasino
    • Ilaria Guarracino
    • Miran Skrap

    Research 14 November 2022 Pages: 707 - 716

    

18. Association of extent of resection and functional outcomes in diffuse low-grade glioma: systematic review & meta-analysis

    • Mustafa Elsheikh
    • Elsie Bridgman
    • Michael Tin Chung Poon

    Review Open access 21 November 2022 Pages: 717 - 724

    

19. Impact of tumor-associated syrinx on outcomes following resection of primary ependymomas of the spinal cord

    • Zach Pennington
    • Anthony L. Mikula
    • Michelle J. Clarke

    Research 18 November 2022 Pages: 725 - 733

    

20. Erythroblastic oncogene B-2 status and intracranial metastatic disease in patients with gastrointestinal cancer: a systematic review

    • Madison Sherman
    • Karolina Gaebe
    • Sunit Das

    Review 13 November 2022 Pages: 735 - 742

21. Plasma IL13Rα2 as a novel liquid biopsy biomarker for glioblastoma

    • Vladimir Khristov
    • Darya Nesterova
    • James Connor

    Research 27 November 2022 Pages: 743 - 752

    

22. Surgical resection versus biopsy in the treatment of primary central nervous system lymphoma: a systematic review and meta-analysis

    • Rafał Chojak
    • Marta Koźba-Gosztyła
    • Bogdan Czapiga

    Review Open access 30 November 2022 Pages: 753 - 761

    

23. Correction to: Preoperative frailty measured by risk analysis index predicts complications and poor discharge outcomes after Brain Tumor Resection in a large multi-center analysis

    • Rachel Thommen
    • Syed Faraz Kazim
    • Christian A. Bowers

    Correction 12 December 2022 Pages: 763 - 763